Netskope (NASDAQ:NTSK) Price Target Raised to $18.00
The Cerbat Gem
Does Stronger EPS, Higher 2026 Targets, and Bigger Buybacks Change The Bull Case For Encompass Health (EHC)?
Simply Wall St
Recursion Pharmaceuticals (RXRX) Reports Weaker Q2 Results, Is The Valuation Gap Too Wide?
Simply Wall St
The Bull Case For Encore Capital Group (ECPG) Could Change Following Record Collections And Upgraded 2026 Guidance
Simply Wall St
Should Sigma Lithium's New ASX Listing Reshape Its Global Capital Access Strategy for SGML Investors?
Simply Wall St
Why Sensient Technologies (SXT) Is Back In The Spotlight
Simply Wall St
Broadcom Stock And 2 Cash Flow Bargains
Simply Wall St
Is Zacks' Upgrade of Esquire Financial (ESQ) Reframing the Bank's Legal-Finance Earnings Narrative?
Simply Wall St
How Investors Are Reacting To Allstate (ALL) Earnings Beat Amid Claims-Practice Scrutiny
Simply Wall St
MongoDB (MDB) Is Down 17.4% After Profit Return, Raised Guidance And New APAC AI Hire - What's Changed
Simply Wall St
Is Exelon's Grid Expansion And Leadership Shuffle Altering The Investment Case For Exelon (EXC)?
Simply Wall St
The Stock Market Has Done This Only 2 Times Since 1871 and Both Times Ended Badly. Could Trump's Policies Raise the Risk of Another Market Meltdown?
Fool.com Headlines
Why GitLab Stock Soared 35% in August and Why It's Already Rocketed Higher
Fool.com Headlines
Pfizer (NYSE:PFE) Downgraded by Wall Street Zen to "Hold"
The Cerbat Gem
Strategy (NASDAQ:MSTR) Price Target Raised to $175.00
The Cerbat Gem
